N-acetylaspartylglutamate in Canavan disease: an adverse effector? - Burlina, A. P.; Ferrari, V.; Divry, P.; Gradowska, W.; Jakobs, C.; Bennett, M. J.; Sewell, A. C.; Dionisi-Vici, C.; Burlina, A. B. (European Journal of Pediatrics, 1999)